Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tamaki Kato
Institution:
Tokyo Women's Medical University
Observed institutions:
Tokyo Women's Medical University,
National Defense Medical College
ORCID:
0000-0002-0148-2510
Observed ORCID:
0000-0002-0148-2510
OpenAlex ID:
A5124059031
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial
2025
·
Jennifer M. Kwon
, Francina Munell
, et al.
·
Nature Medicine
·
23
PDF
Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial
2026
·
Jennifer M. Kwon
, Francina Munell
, et al.
·
Nature Medicine
·
2
PDF
Outcomes of combination therapy with nusinersen, onasemnogene abeparvovec, and risdiplam over 3.5 years in a patient with prenatally diagnosed spinal muscular atrophy type 0: A case report
2026
·
Yukimune Okubo
, Noriko Togashi
, et al.
·
Brain and Development
·
1
Intrathecal onasemnogene abeparvovec (OAV101 IT) for treatment-experienced patients with spinal muscular atrophy (SMA): Phase 3B, open-label strength study
2025
·
Jennifer Kwon
, Francina Munell
, et al.
·
Journal of the Neurological Sciences
Centralized rapid genetic diagnosis of combined immunodeficiency in Japan
2025
·
Tamaki Kato
, Yumi Ogura
, et al.
·
Pediatrics International
PDF
Show more works
View as search
Works count:
5
Citation count:
26
H-index:
2
I10-index:
1
Year
Topic
Type